Efficacy of therapeutic drugs for vertigo.
D000328:Adult; D000654:Amobarbital / Q000592:standards / Q000627:therapeutic use; D004111:Dimenhydrinate / Q000592:standards / Q000627:therapeutic use; D004585:Electrooculography; D005260:Female; D006634:Histamine H1 Antagonists / Q000592:standards / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008614:Meperidine / Q000592:standards / Q000627:therapeutic use; D008875:Middle Aged; D009759:Nystagmus, Pathologic; D011187:Posture; D011398:Promethazine / Q000592:standards / Q000627:therapeutic use; D014309:Tripelennamine / Q000592:standards / Q000627:therapeutic use; D014717:Vertigo / Q000188:drug therapy*; D014724:Vestibular Function Tests
D006634:Histamine H1 Antagonists; D014309:Tripelennamine; D008614:Meperidine; D011398:Promethazine; D000654:Amobarbital; D004111:Dimenhydrinate